Monitoring HOTTIP levels on extracellular vesicles for predicting recurrence in surgical non-small cell lung cancer patients
Authors:
- Bing HanBHBing Han
- Ramón María MarradesRMRamón María Marrades
- Nuria ViñolasNVNuria Viñolas
- Yangyi HeYHYangyi He
- Jordi CanalsJCJordi Canals
- Tania DíazTania Díaz
- Laureano MolinsLMLaureano Molins
- Daniel MartinezDMDaniel Martinez
- Jorge MoisésJMJorge Moisés
- David SánchezDSDavid Sánchez
- Marc BoadaMBMarc Boada
- Melissa Acosta-PlasenciaMelissa Acosta-Plasencia
Open Access
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Translational Oncology
- Vol. 14 (8) , 101144
Abstract
No abstract availableKeywords
Funding Information
- Agencia Estatal de Investigación
- European Commission (SAF2017-88606-P)
- European Regional Development Fund
- Gobierno de España Ministerio de Ciencia e Innovación
This publication has 32 references indexed in Scilit:
- Plasma extracellular RNA profiles in healthy and cancer patientsScientific Reports, 2016
- Postoperative follow-up strategy based on recurrence dynamics for non-small-cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2016
- US lung cancer trends by histologic typeCancer, 2014
- Liquid biopsy: monitoring cancer-genetics in the bloodNature Reviews Clinical Oncology, 2013
- Recurrence Dynamics for Non–Small-Cell Lung Cancer: Effect of Surgery on the Development of MetastasesJournal of Thoracic Oncology, 2012
- A long noncoding RNA maintains active chromatin to coordinate homeotic gene expressionNature, 2011
- Randomised study of adjuvant chemotherapy for completely resected p-stage I–IIIA non-small cell lung cancerBritish Journal of Cancer, 2006
- Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trialThe Lancet Oncology, 2006
- Pathogenesis of Lung CancerAmerican Journal of Respiratory Cell and Molecular Biology, 2005
- A Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II or IIIa Non–Small-Cell Lung CancerNew England Journal of Medicine, 2000